Quanterix (QTRX)

• Market cap: $155M
• 1 day: -13.16%
• 5 days: 8.91%
• 1 month: 0%
• 3 months: -37.85%
• 6 months: -56.75%
• Year to date: -48.68%
• 1 year: -36.05%
• 5 years: -94.49%
• 10 years: -81.11%
• Sector: Healthcare
• Industry: Medical Devices

About: Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Employees: 450